论文部分内容阅读
骨髓移植(BMT)可用于治疗某些恶性血液病,但BMT 后患者肺功能常恶化。肺功能测定是否可用于监测BMT 后患者的病情进展,提醒临床医师警惕可能发生的肺炎,目前仍无定论。为此对39例恶性血液病患者在BMT 前后进行了一系列肺功能测定,包括用力肺活量(FVC)、第1秒用力呼气容积(FEV_1)、肺总量(TLC)、CO 转移系数(TLco)。第1组为18例BMT 后发生间质性肺炎的患者,包括17例去除T细胞的异体BMT 和1例自体BMT;第2组为21例BMT 后未发生肺炎的患者,包括17例异体BMT 和4
Bone marrow transplantation (BMT) can be used to treat certain hematologic malignancies, but patients with lung function often deteriorate after BMT. Whether pulmonary function tests can be used to monitor patient progression after BMT reminds clinicians to be alert to possible pneumonia is still inconclusive. To date, a series of lung function tests were performed in 39 patients with hematologic malignancies before and after BMT, including FVC, FEV 1, TLC, TLco ). Group 1 consisted of 18 patients with interstitial pneumonitis after BMT, including 17 T-cell allogeneic BMT and 1 autologous BMT. Group 2 included 21 patients without pneumonia after BMT, including 17 allogeneic BMT And 4